Page last updated: 2024-10-26

valproic acid and Bardet-Biedl Syndrome

valproic acid has been researched along with Bardet-Biedl Syndrome in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Bardet-Biedl Syndrome: An autosomal recessive disorder characterized by RETINITIS PIGMENTOSA; POLYDACTYLY; OBESITY; MENTAL RETARDATION; hypogenitalism; renal dysplasia; and short stature. This syndrome has been distinguished as a separate entity from LAURENCE-MOON SYNDROME. (From J Med Genet 1997 Feb;34(2):92-8)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mockel, A1
Obringer, C1
Hakvoort, TB1
Seeliger, M1
Lamers, WH1
Stoetzel, C1
Dollfus, H1
Marion, V1

Other Studies

1 other study available for valproic acid and Bardet-Biedl Syndrome

ArticleYear
Pharmacological modulation of the retinal unfolded protein response in Bardet-Biedl syndrome reduces apoptosis and preserves light detection ability.
    The Journal of biological chemistry, 2012, Oct-26, Volume: 287, Issue:44

    Topics: Animals; Apoptosis; Bardet-Biedl Syndrome; Biological Transport; Caspase 12; Caspase Inhibitors; Cha

2012